2012-09-12 16:20:19 - Human Papilloma Virus Partnering 2007-2012 - a new market research report on companiesandmarkets.com
The Human Papilloma Virus Partnering 2007-2012 report provides understanding and access to the human papilloma virus partnering deals and agreements entered into by the worlds leading healthcare companies.
â¢ Trends in human papilloma virus partnering deals
â¢ Top human papilloma virus deals by value
â¢ Deals listed by company A-Z, industry sector, stage of development, technology type
The Human Papilloma Virus Partnering 2007-2012 provides understanding and access to the human papilloma virus partnering deals and agreements entered into by the worlds leading healthcare companies.
The report provides an analysis of human papilloma virus partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors human papilloma virus technology. These deals tend
to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.
Understanding the flexibility of a prospective partner´s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered â contract documents provide this insight where press releases do not.
This data driven report contains over 70 links to online copies of actual human papilloma virus deals and contract documents as submitted to the Securities Exchange Commission by companies and their partners, where available. Contract documents provide the answers to numerous questions about a prospective partner´s flexibility on a wide range of important issues, many of which will have a significant impact on each party´s ability to derive value from the deal.
The initial chapters of this report provide an orientation of human papilloma virus partnering trends.
Chapter 1 provides an introduction to the report, whilst chapter 2 provides an overview of the trends in human papilloma virus partnering since 2007, including a summary of deals by industry sector, stage of development, deal type, and technology type. Numerous tables provide outline financial trends.
Chapter 3 provides an overview of the leading human papilloma virus deals since 2007. Deals are listed by headline value, signed by bigpharma, most active bigpharma. Where the deal has an agreement contract published at the SEC a link provides online access to the contract.
Chapter 4 provides a comprehensive directory of human papilloma virus partnering deals signed and announced since 2007. The chapter is organized by company A-Z, stage of development at signing, deal type (collaborative R&D, co-promotion, licensing etc), and technology type. Each deal title links via Weblink to an online version of the deal record, and where available the contract document, providing easy access to each contract document on demand.
In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of human papilloma virus technologies and products.
Human Papilloma Virus Partnering 2007-2012 is intended to provide the reader with an in-depth understanding and access to human papilloma virus trends and structure of deals entered into by leading companies worldwide.
This data driven report includes:
â¢ Trends in human papilloma virus dealmaking in the biopharma industry since 2007
â¢ Access to summary headline, upfront, milestone and royalty data
â¢ The leading human papilloma virus deals by value since 2007
In Human Papilloma Virus Partnering 2007-2012, the available deals are listed by:
â¢ Headline value
â¢ Upfront payment value
â¢ Royalty rate value
â¢ Company A-Z
â¢ Industry sector
â¢ Stage of development at signing
â¢ Deal component type
â¢ Technology type
Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.This is an on-demand report. After purchase, this report will be sent to you within 3 days.
Click for report details: www.companiesandmarkets.com/Market/Healthcare-and-Medical/Market ..
Browse all Healthcare and Medical Market Research Reports www.companiesandmarkets.com/Market/Healthcare-and-Medical/Market ..
Browse all Healthcare and Medical Company Profile Reports www.companiesandmarkets.com/Market/Healthcare-and-Medical/Compan ..
Browse all Latest Market Research Reports www.companiesandmarkets.com/Market/All/Market-Research?aCode=f3f ..
Companiesandmarkets.com is a leading online business information aggregator with over 300,000 market reports and company profiles available to our clients. Our extensive range of reports are sourced from the leading publishers of business information and provide clients with the widest range of information available. In terms of company profiles, Companiesandmarkets.comâs online database allows clients access to market and corporate information to over 100,000 different companies. We provide clients with a fully indexed database of information where clients can find specific market reports on their niche industry sectors of interest.